These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3976380)

  • 1. Gynecological follow-up of parkinsonian patients on long-term bromocriptine treatment.
    Grönroos M; Salmi T; Erkkola R; Liukko P; Rinne UK
    Acta Obstet Gynecol Scand; 1985; 64(1):81-2. PubMed ID: 3976380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third interim report of the nationwide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients.
    Nakanishi T; Kanazawa I; Goto I; Iwata M; Kowa H; Mannen T; Mizuno Y; Nishitani H; Ogawa N; Takahashi A
    Eur Neurol; 1990; 30 Suppl 1():3-8. PubMed ID: 2178938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine in parkinsonism. A long-term study.
    Lees AJ; Haddad S; Shaw KM; Kohout LJ; Stern GM
    Arch Neurol; 1978 Aug; 35(8):503-5. PubMed ID: 666607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromocriptine and Parkinson's disease: a 16-hour clinical evaluation.
    Grøn U; Friis ML; Pakkenberg H
    Acta Neurol Scand; 1980 Feb; 61(2):131-6. PubMed ID: 6994422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second interim report of the nation-wide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients.
    Nakanishi T; Iwata M; Goto I; Kanazawa I; Kowa H; Mannen T; Mizuno Y; Nishitani H; Ogawa N; Takahashi A
    Eur Neurol; 1989; 29 Suppl 1():3-8. PubMed ID: 2714305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of uterine neoplasia in patients on bromocriptine.
    Besser GM; Thorner MO; Wass JA; Doniach I; Canti G; Curling M; Grudziniskas JG; Setchell ME
    Br Med J; 1977 Oct; 2(6091):868. PubMed ID: 922331
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bromocriptine as the 1st treatment of Parkinson's disease. Long term results].
    Rascol A; Montastruc JL; Guiraud-Chaumeil B; Clanet M
    Rev Neurol (Paris); 1982; 138(5):401-8. PubMed ID: 7146724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromocriptine in the treatment of parkinsonism.
    Parkes JD
    Drugs; 1979 May; 17(5):365-82. PubMed ID: 37066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythromelalgia-like eruption in parkinsonian patients treated with bromocriptine.
    Eisler T; Hall RP; Kalavar KA; Calne DB
    Neurology; 1981 Oct; 31(10):1368-70. PubMed ID: 6213882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical assessment of therapeutic results of Ergolactyn (bromocriptine) in Parkinson's disease].
    Kuran W; Kulczycki J
    Neurol Neurochir Pol; 1993; 27(4):507-13. PubMed ID: 8247238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.
    Parkes JD; Debono AG; Marsden CD
    J Neurol Neurosurg Psychiatry; 1976 Nov; 39(11):1101-8. PubMed ID: 1036999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy of bromocriptine in Parkinson disease.
    Lieberman A; Kupersmith M; Neophytides A; Casson I; Durso R; Foo SH; Khayali M; Bear G; Goldstein M
    Neurology; 1980 May; 30(5):518-23. PubMed ID: 6768003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of bromocriptine in the treatment of parkinsonism.
    Fahn S; Cote LJ; Snider SR; Barrett RE; Isgreen WP
    Neurology; 1979 Aug; 29(8):1077-83. PubMed ID: 572493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined bromocriptine-levodopa therapy early in Parkinson's disease.
    Rinne UK
    Neurology; 1985 Aug; 35(8):1196-8. PubMed ID: 4022354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bromocriptine in Parkinsonian syndromes. Results obtained in a group of patients treated for 8 months].
    Quattrini A; Paggi A; Del Pesce M; Di Bella P
    Riv Patol Nerv Ment; 1978; 99(3):150-63. PubMed ID: 752907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nation-wide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients: analysis on the maintenance and the change of the original mode of treatment.
    Nakanishi T; Kanazawa I; Iwata M; Goto I; Kowa H; Mannen T; Mizuno Y; Nishitani H; Ogawa N; Takahashi A
    Eur Neurol; 1992; 32 Suppl 1():23-9. PubMed ID: 1425818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment with high-dosage bromocriptine in advanced Parkinson's disease.
    Jansen EN; Meerwaldt JD
    Adv Neurol; 1987; 45():539-42. PubMed ID: 3103396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment of parkinsonism with bromocriptine.
    Calne DB; Plotkin C; Williams AC; Nutt JG; Neophytides A; Teychenne PF
    Lancet; 1978 Apr; 1(8067):735-8. PubMed ID: 76747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
    Kartzinel R; Shoulson I; Calne DB
    Neurology; 1976 Jun; 26(6 PT 1):511-3. PubMed ID: 778655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleuropulmonary involvement during bromocriptine treatment.
    Kinnunen E; Viljanen A
    Chest; 1988 Nov; 94(5):1034-6. PubMed ID: 3180854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.